Naomi Rahimi‐Levene

<scp>BNT162b2 COVID</scp>‐19 vaccine is significantly less effective in patients with hematologic malignancies

Katrin Herzog Tzarfati, Odit Gutwein, Arie Apel et al. · American Journal of Hematology · 2021 · 167 citations · Full text

Veterinary Medicine, Hematology, Immunology +17

Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma

‪Yasmin Maor‬‏, Dani Cohen, Nir Paran et al. · EClinicalMedicine · 2020 · 70 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Conventional Dose Fludarabine-based Regimens are Effective but have Excessive Toxicity in Elderly Patients with Refractory Chronic Lymphocytic Leukemia

Lev Shvidel, Mordechai Shtalrid, Osnat Bairey et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2003 · 52 citations

Pharmacy, Oncology, Pharmacotherapy +16

Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine

H Maayan, Ilya Kirgner, Odit Gutwein et al. · Journal of Thrombosis and Haemostasis · 2021 · 47 citations · Full text

Medicine, Hematology, Immunology +10

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis et al. · The Lancet Haematology · 2022 · 47 citations

Medicine, Oncology, Pharmacotherapy +12